by Quynh Nguyen for DealStreetAsia

“Temasek-backed Vertex Ventures announced that its healthcare-focused venture capital arm Vertex Ventures HC (VVHC) has launched a $200 million Fund III to support life sciences and medical technology companies.

VVHC, a woman-led global healthcare investment firm, will seek investment opportunities in early-stage companies that demonstrate disruptive technologies, breakthrough research, and a clear path towards developing new medicines for patients…”

Continue reading at the original source, linked here.